Jove
Visualize
Contact Us

Related Experiment Videos

Small molecules that reactivate mutant p53.

V J N Bykov1, G Selivanova, K G Wiman

  • 1Department of Oncology-Pathology, Cancer Center Karolinska, SE-171 76 Stockholm, Sweden.

European Journal of Cancer (Oxford, England : 1990)
|August 23, 2003
PubMed
Summary

Mutant p53 proteins are found in half of human tumors, enabling cancer cell survival. Small molecules that restore wild-type p53 function show promise for developing new anticancer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3s.

Oncogene·2023
Same author

Introduction to Nobel Conference: 'The Cell Cycle and Cell Death in Disease'.

Journal of internal medicine·2017
Same author

Understanding cell cycle and cell death regulation provides novel weapons against human diseases.

Journal of internal medicine·2017
Same author

PRIMA-1<sup>MET</sup> induces mitochondrial apoptosis through activation of caspase-2.

Oncogene·2017
Same author

PRIMA-1Met induces mitochondrial apoptosis through activation of caspase-2.

Oncogene·2016
Same author

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.

Cell death & disease·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Approximately 50% of human tumors harbor mutations in the p53 tumor suppressor gene.
  • Mutant p53 proteins facilitate tumor cell evasion of apoptosis and cell cycle arrest.
  • Elevated expression of mutant p53 is a common feature in many cancers.

Purpose of the Study:

  • To explore the therapeutic potential of restoring wild-type p53 function in cancer.
  • To identify small molecules capable of reactivating mutant p53.
  • To investigate novel strategies for cancer treatment targeting the p53 pathway.

Main Methods:

  • Identification and characterization of small molecules targeting mutant p53.
  • Assays to evaluate the restoration of wild-type p53 conformation and function.
  • Assessment of apoptosis induction in tumor cells expressing mutant p53.

Main Results:

  • Several classes of small molecules have been identified that can revert mutant p53 to its wild-type conformation.
  • These molecules effectively restore the tumor-suppressive functions of p53.
  • Restoration of wild-type p53 function leads to significant apoptosis in tumor cells.

Conclusions:

  • Targeting mutant p53 with small molecules represents a promising therapeutic strategy for cancer.
  • Restoring wild-type p53 function can induce tumor-specific cell death.
  • These findings provide a foundation for developing novel anticancer drugs based on p53 reactivation.

Related Experiment Videos